Loading stock data…
Translational Development Acqui (TDAC)
$10.70+0.01 (+0.09%)
Market OpenUpdated 2:53 PM EDT
Translational Development Acquisition Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Translational Development Acquisition Corp. in the Financial Services sector is trading at $10.70 with a market capitalization of $235M. The stock is currently near its 52-week high of $10.80, remaining 1.6% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. Risk note: RSI 29 is oversold, raising the odds of a near-term bounce. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 29) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$281,161↓ | -$162,345↑ | -$213,658↑ | -$221,127↑ | -$347,408 |
| Net Income | $1.33M↓ | $1.60M↓ | $1.66M↑ | $1.62M↑ | $1.48M |
Peer Comparison
JPMBACGS
Fundamentals
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or mor...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$235.29M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
38.36
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.52%
Volume
Today's trading volume
3,396
